| |
Group
|
Pre test
|
Post test
|
24 h-post test
|
48 h-post test
|
|---|
|
LF (ms2)
|
Placebo
|
66.86 ± 7.09
|
66.21 ± 8.04
|
66.91 ± 8.20a
|
65.12 ± 3.87
|
|
OFI
|
62.79 6.04c
|
66.90 ± 10.37d
|
52.83 ± 4.47acd
|
58.11 ± 5.78
|
|
HF (ms2)
|
Placebo
|
33.00 ± 7.03
|
28.74 ± 2.72
|
32.98 ± 8.20
|
33.02 ± 4.46
|
|
OFI
|
33.38 ± 3.52
|
34.31 ± 9.31
|
31.39 ± 4.39
|
36.81 ± 8.54
|
|
LF/HF
|
Placebo
|
2.15 ± 0.69
|
2.32 ± 0.33
|
2.20 ± 0.83
|
2.01 ± 0.33
|
|
OFI
|
1.90 ± 0.26
|
2.11 ± 0.68
|
1.71 ± 0.23
|
1.69 ± 0.58
|
|
RMSSD
|
Placebo
|
51.68 ± 7.40
|
42.18 ± 9.64
|
46.55 ± 9.20
|
45.53 ± 7.93b
|
|
OFI
|
59.40 ± 8.44e
|
48.63 ± 6.18ef
|
54.85 ± 9.44
|
58.48 ± 7.84bf
|
- All data are presented as means±SD. LF Low Frequency, HF High Frequency, LF/HF Low-high frequency ratio; rMSSD Root Mean Square of the Successive Differences. a,b,c,d,e and f denote significant differences (p < 0.05) between groups and within the same group
